This article nicely highlights how #biologics show a steady rise in the #pharmaceutical #market in part due to their evolution to newer modalities such as #bispecifics and #antibodydrugconjugates (lnkd.in/eWnVyNeZ).
#liver #granuloma formation and #TNF #IL6 #cytokine levels are two of the read outs that we offer to assess #immunocompetence and resistance of wild type and #mutated #mice to #listeria #bacterial #infection
Find our more at: lnkd.in/dc-qXiz4
Our partner @InfrafrontierEU got a new website! If you work on #Cancer, #RD or other #humandiseases, take a look! This European RI archives & distributes mouse models for #preclinicalstudies and offers outstanding services for your research. Check it out!
infrafrontier.eu
We are happy to have coauthored the study by Zhao Y et al at Scientific Reports (lnkd.in/dNk5iPke) where the human TNF transgenic #hTNFTg #Tg197 mice were used as #preclinical tool to show that #TNF and #Dexamethasone impair #bone growth in an additive manner.
Excited to share this beautiful histopathology image showing #fibrosis in the #glomeruli of the #kidneys of our new #humanized #IL23 #animalmodel of #lupus #autoimmunity developed by our R&D scientists.
Newly published @Biomedcode
.... a novel transmembrane #TNF driven #mouse model of human #spondyloarthritis.
A #translational tool for the study of #SpA pathogenesis and the evaluation of human #therapeutics.
arthritis-research.biomedcen…
NEW #JobOpportunity at Biomedcode for the position of a #ResearchTechnician with experience in #Histology and basic #MolecularBiologyTechniques.
For more information visit biomedcode.com/career-opport… and send your CV at [email protected]
#Mice, #DNAisolation, #PCR
Biomedcode retweeted
Cannot but like it! Congrats to Vasiliki and co-authors Ana and Alejandro! Innate success!
A new review article by #Koliaraki_lab & @KolliasLab is now published @JExpMed: #Ιnnate mechanisms in the #cancer_microenvironment. The emerging role of the #mesenchyme.
@BSRC_Fleming #innate_immunity #CAFs
fleming.gr/research/fleming-…
Novel and established #preclinical platforms developed at #Biomedcode support that pro-Infliximab not only provides equivalent #therapeutic efficacy to #Infliximab but also maintains mouse immunity against #Listeria infection #Tg197, #huTNFTg, #drug development











